Accessome
Cancer: Everybody’s Enemy
Cancer is everyone’s biggest fear, no matter the country. This widespread condition has certainly evolved in the urban environment, but it is still an predominant issue in the rural As well. Cancer claims live every day and bring sorrow to families worldwide, simultaneously acquiring a popularity among the greatest feared conditions. No one is safe from the grasp of this villain. It’s ,,fame" can also be blamed on the fact that, even is some variations can be prevented and eradication of the tumour is possible in some cases, none are long-lastingly curable: that is until now.
T-cell Leukaemia
T-cell acute lymphoblastic leukaemia, or T-ALL, is an aggressive(fast-spreading and progressing) bone marrow and blood cancer. T-cells are white blood cells made in the bone marrow. They help the body to fight off infections. Researchers think several genetic changes (mutations) in the thymus, a small organ found behind the breastbone were these cells travel, cause T-ALL. These changes interfere with normal T-cell development within the thymus.
Before the breakthrough was achieved, T-ALL was a terrifying prospect. The statistic is grave: Around one-third of patients experience T-ALL relapse (return of the cancer) within one to two years. That means that even people who beat the condition aren’t safe. More so, the acute nature of this cancer manifests in a fast development, meaning a shorter period of time for early treatment. All of these factors contribute to the ”challenging” status of this condition.
Cure for the Incurable A beacon of hope for T-ALL patients has come from a scientifical field with largely undiscovered potential. Gene editing has earned its fame from CRISPR, the DNA sequence that acts as a part of a bacteria’s immune system, but can be guided to recognize genetic material in the human genome as well. In this case, the technique used to battle the cancer is called base editing, and it is an advanced form of CRISPR that changes individual DNA letters inside living cells with high precision. The treatment, named CAR-T cell immunotherapy, has a relatively easy to understand process. The patients T- Cells are modified to carry a customized protein called a chimeric antigen receptor (CAR). This receptor helps the modified cell identify unique markers or "flags" on cancer cells and destroy them. Basically, the modified cells look for the cancerous cells and destroy them. Seems simple enough, right? Well, the struggle comes from the modification normal T-Cells have to undergo. The designed cells could have reacted to one another and, as a result, destroyed themselves. To fix this issue, scientists removed CD7, the marker that identifies cells as T-Cells, from the genetic material send to attack the cancerous cells. They also removed another marker, CD52, to make sure the received cells wont be suppressed.
The results are highly positive: 64% of the treated patients remained disease-free, with the first patients now three years disease-free and off treatment and 82% of patients achieved very deep remissions(little or no risk of disease progression) after BE-CAR7, enabling them to proceed to stem cell transplant without disease. This technique has began being used in other blood cancers due to its effectivenes in patients that don’t react to other treatments.
Medicine in the Future Genetic editing has opened many doors in the field of medicine. Addressing problems from the root can treat and even prevent certain conditions from occurring. This recent discovery raises an important question, tough: If we can cure an incurable cancer, what other important breakthroughs can we achieve?